Kazusamycin A

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H558170

CAS#: 92090-94-3

Description: Kazusamycin A is a new antitumor antibiotic. It has a structure characteristic of an unsaturated, branched-chain fatty acid with a terminal delta-lactone ring.


Chemical Structure

img
Kazusamycin A
CAS# 92090-94-3

Theoretical Analysis

Hodoodo Cat#: H558170
Name: Kazusamycin A
CAS#: 92090-94-3
Chemical Formula: C33H48O7
Exact Mass: 556.34
Molecular Weight: 556.740
Elemental Analysis: C, 71.19; H, 8.69; O, 20.12

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Antibiotic 81-484; Antibiotic CL1957B; Kazusamycin A; PD 114721;

IUPAC/Chemical Name: 2,10,12,16,18-Nonadecapentaenoic acid, 19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-17-ethyl-6-hydroxy-9-(hydroxymethyl)-3,5,7,11,15-pentamethyl-8-oxo-

InChi Key: KZMHNEBMQDBQND-MRBODPGGSA-N

InChi Code: InChI=1S/C33H48O7/c1-8-27(13-14-29-24(5)12-15-31(37)40-29)17-21(2)10-9-11-22(3)18-28(20-34)33(39)26(7)32(38)25(6)16-23(4)19-30(35)36/h9,11-15,17-19,21,24-26,28-29,32,34,38H,8,10,16,20H2,1-7H3,(H,35,36)/b11-9+,14-13+,22-18+,23-19+,27-17+

SMILES Code: O=C(O)/C=C(C)/CC(C)C(O)C(C)C(C(CO)/C=C(C)/C=C/CC(C)/C=C(CC)/C=C/C1C(C)C=CC(O1)=O)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 556.74 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Ando R, Amano Y, Nakamura H, Arai N, Kuwajima I. Design, synthesis, and evaluation of novel kazusamycin A derivatives as potent antitumor agents. Bioorg

Med Chem Lett. 2006 Jun 15;16(12):3315-8. Epub 2006 Apr 17. PubMed PMID: 16617017.



2: Komiyama K, Okada K, Oka H, Tomisaka S, Miyano T, Funayama S, Umezawa I. Structural study of a new antitumor antibiotic, kazusamycin. J Antibiot (Tokyo).

1985 Feb;38(2):220-9. PubMed PMID: 3922934.



3: Umezawa I, Komiyama K, Oka H, Okada K, Tomisaka S, Miyano T, Takano S. A new antitumor antibiotic, kazusamycin. J Antibiot (Tokyo). 1984 Jul;37(7):706-11. PubMed PMID: 6432763.



4: Arai N, Chikaraishi N, Omura S, Kuwajima I. First total synthesis of the antitumor compound (-)-kazusamycin A and absolute structure determination. Org Lett. 2004 Aug 19;6(17):2845-8. PubMed PMID: 15330629.



5: Sawamura M. [Growth inhibitory effect of a new anticancer antibiotics, kazusamycin A, on human transitional cancer cell lines in vitro]. Nihon Hinyokika Gakkai Zasshi. 1992 May;83(5):627-35. Japanese. PubMed PMID: 1495200.



6: Komiyama K, Okada K, Hirokawa Y, Masuda K, Tomisaka S, Umezawa I. Antitumor activity of a new antibiotic, kazusamycin. J Antibiot (Tokyo). 1985 Feb;38(2):224-9. PubMed PMID: 3922935.



7: Umezawa I, Komiyama K. [Studies on the new antibiotic kazusamycin and related

substances]. Gan To Kagaku Ryoho. 1987 Mar;14(3 Pt 2):858-64. Japanese. PubMed PMID: 3105461.



8: Umezawa I. [Biological activities of a new antitumor antibiotics]. Gan To Kagaku Ryoho. 1984 Dec;11(12 Pt 2):2674-80. Japanese. PubMed PMID: 6439122.



9: Tunac JB, Graham BD, Dobson WE, Lenzini MD. Novel antitumor antibiotics, CI-940 (PD 114,720) and PD 114,721. Taxonomy, fermentation and biological activity. J Antibiot (Tokyo). 1985 Apr;38(4):460-5. PubMed PMID: 3924872.



10: Roberts BJ, Hamelehle KL, Sebolt JS, Leopold WR. In vivo and in vitro anticancer activity of the structurally novel and highly potent antibiotic CI-940 and its hydroxy analog (PD 114,721). Cancer Chemother Pharmacol. 1986;16(2):95-101. PubMed PMID: 3081269.



11: Yoshida E, Nishimuta Y, Naito K, Watanabe Y, Tomisaka S, Okura A, Komiyama K, Umezawa I. The effect of kazusamycin on the growth of murine solid tumors and their spontaneous metastasis. J Antibiot (Tokyo). 1987 Mar;40(3):391-3. PubMed PMID: 3106290.